About this Journal Submit a Manuscript Table of Contents
Case Reports in Emergency Medicine
Volume 2013 (2013), Article ID 125043, 3 pages
http://dx.doi.org/10.1155/2013/125043
Case Report

Critical Pertussis in a Young Infant Requiring Mechanical Ventilation

Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Pasteur 38, Bandung, West Java 40161, Indonesia

Received 13 March 2013; Accepted 9 April 2013

Academic Editors: L. Bojić, A. K. Exadaktylos, P. Iannone, K. Imanaka, and H. P. Wu

Copyright © 2013 Heda Melinda Nataprawira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Gregory, “Pertussis: a disease affecting all ages,” American Family Physician, vol. 74, no. 3, pp. 420–426, 2006. View at Scopus
  2. Manitoba Health Communicable Disease Control Unit, Pertussis/Parapertussis, Communicable Disease Management Protocol, Manitoba, Canada, 2001.
  3. J. S. Burr, T. L. Jenkins, R. Harrison et al., “The collaborative pediatric critical care research network critical pertussis study: collaborative research in pediatric critical care medicine,” Pediatric Critical Care Medicine, vol. 12, no. 4, pp. 387–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Heininger, “Update on pertussis in children,” Expert Review of Anti-Infective Therapy, vol. 8, no. 2, pp. 163–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. M. Nataprawira, F. Cahayasari, and A. Kashmir, “Pertussis-like syndrome or pertussis: a delay diagnosis,” Paediatr Indones, vol. 52, pp. 28–31, 2012.
  6. E. L. Murray, D. Nieves, J. S. Bradley, et al., “Characteristics of severe Bordetella pertussis infection among infants 90 days of age admitted to pediatric intensive care unit-Southern California, September 2009-June 2011,” Pediatric Infectious Disease Journal, vol. 2, no. 1, pp. 1–6, 2013.
  7. J. D. Cherry, R. Harrison, J. S. Bradley, et al., “Pertussis in young infants. Guidance for Clinicians,” 2010.
  8. Centers for Disease Control and Prevention, “Pertussis (whooping cough): Surveillance & Reporting,” 2010, http://www.cdc.gov/pertussis/surv-reporting.html.
  9. World Health Organization and Department of Vaccines and Biologicals, “Pertussis surveillance. A global meeting,” Tech. Rep. WHO/V&B/01.19, World Health Organization, Geneva, Switzerland, 2001.
  10. C. D. Paddock, G. N. Sanden, J. D. Cherry et al., “Pathology and pathogenesis of fatal Bordetella pertussis infection in infants,” Clinical Infectious Diseases, vol. 47, no. 3, pp. 328–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Heininger, W. J. Kleemann, and J. D. Cherry, “A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants,” Pediatrics, vol. 114, no. 1, pp. e9–15, 2004. View at Scopus
  12. C. Pierce, N. Klein, and M. Peters, “Is leukocytosis a predictor of mortality in severe pertussis infection?” Intensive Care Medicine, vol. 26, no. 10, pp. 1512–1514, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Donoso, J. León, M. Ramírez, G. Rojas, and B. Oberpaur, “Pertussis and fatal pulmonary hypertension: a discouraged entity,” Scandinavian Journal of Infectious Diseases, vol. 37, no. 2, pp. 145–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Centers for Disease Control and Prevention, National Immunization Program: Epidemiology and Prevention of Vaccine-Preventable Diseases, “The Pink Book”, Pertussis, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 8th edition, 2003.
  15. J. M. Langley, S. A. Halperin, F. D. Boucher, and B. Smith, “Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis,” Pediatrics, vol. 114, no. 1, pp. e96–101, 2004. View at Scopus
  16. J. M. Zuckerman, “Macrolides and ketolides: azithromycin, clarithromycin, telithromycin,” Infectious Disease Clinics of North America, vol. 18, no. 3, pp. 621–649, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Centers for Disease Control and Prevention, “Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis,” 2005, http://www.cdc.gov/mmwr/preview/mmwrhtml.
  18. M.-P. Preziosi and M. E. Halloran, “Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity,” Archives of Disease in Childhood, vol. 92, pp. 970–975, 2003.